Abstract The present invention is concerned with an improved process for the production of highly active optical isomers of (-) 7 or 8 fluorodibenzo b,f!thiepin-3-carboxylic acid-5-oxide having the structural formula ##STR1## in which the fluoro substituent replaces a hydrogen in the 7 or 8 position. The two active isomers represented by formula II are S(-)7-fluorodibenzo b,f!thiepin-3-carboxylic acid-5-oxide and R(-)8-fluorodibenzo b,f!thiepin-3-carboxylic acid-5-oxide. It is especially concerned with the resolution of the racemic 7 or 8 fluorodibenzo b,f!thiepin-3-carboxylic acid-5-oxide by first forming and separating diastereomers of said racemic carboxylic acids by salt formation with brucine or ephedrine followed by crystallization and regeneration of the desired (-) isomers and recycling of the (+) isomer by racemization of the regenerated isomer. The compounds obtained in high yield by this process are highly active prostaglandin antagonists which are useful in treating a variety of conditions such as allergic asthma.
An improved process for the preparation of (-) 7 or (-) 8-fluoro-dibenzo b,f!thiepin-3-carboxylic acid-5-oxide of the formula I, having an enantiomeric purity of at least 70 percent, ##STR6## which comprises: (1) Heating the racemic sulfoxide acid, (7 or 8)-fluorodibenzo b,f!thiepin-3-carboxylic acid-5-oxide with an equimolar amount of brucine to form a diastereoisomeric mixture of brucine salts of the corresponding (-) and (+) acids; (2) Recycling the major portion of the brucine (+) acid salt by crystallization, acidification and racemization to regenerate the starting racemic sulfoxide acid; (3) Recovering the brucine (-) acid salt by evaporation of the crystallization mother liquors; (4) Acidifying said brucine (-) acid salt to produce the desired sulfoxide acid product and recovering said product by crystallization.
Claim 2
Dependent Claim
119 words
An improved process for the preparation of (-) 7 or (-) 8-fluoro-dibenzo b,f!thiepin-3-carboxylic acid-5-oxide of the formula I, having an enantiomeric purity of at least 70 percent, ##STR6## which comprises: (1) Heating the racemic sulfoxide acid, (7 or 8)-fluorodibenzo b,f!thiepin-3-carboxylic acid-5-oxide with an equimolar amount of brucine to form a diastereoisomeric mixture of brucine salts of the corresponding (-) and (+) acids; (2) Recycling the major portion of the brucine (+) acid salt by crystallization, acidification and racemization to regenerate the starting racemic sulfoxide acid; (3) Recovering the brucine (-) acid salt by evaporation of the crystallization mother liquors; (4) Acidifying said brucine (-) acid salt to produce the desired sulfoxide acid product and recovering said product by crystallization.
Claim 3
Dependent Claim
11 words
The brucine salt of (-) 7 or 8 fluorodibenzo b,f!thiepin-3-carboxylic acid-5-oxide.
Claim 4
Dependent Claim
11 words
The brucine salt of (-) 7 or 8 fluorodibenzo b,f!thiepin-3-carboxylic acid-5-oxide.
Claim 5
Dependent Claim
10 words
The brucine salt of (+) 7 or 8-fluorodibenzo b,f!thiepin-3-carboxylic acid-5-oxide.
Claim 6
Dependent Claim
10 words
The brucine salt of (+) 7 or 8-fluorodibenzo b,f!thiepin-3-carboxylic acid-5-oxide.